Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Leukemia. 2024 May;38(5):1081-1085. doi: 10.1038/s41375-024-02216-8. Epub 2024 Mar 9.
Myeloproliferative neoplasms (MPN) are associated with inferior pregnancy outcome, however, little is known about fertility and childbearing potential in women with MPN. In this study we aimed to describe reproductive patterns, as well as to quantify risk of miscarriage and stillbirth. Women aged 15-44 years with an MPN diagnosis 1973-2018, were identified in Swedish health care registers, and age-matched 1:4 to population controls. We identified 1141 women with MPN and 4564 controls. Women with MPN had a lower rate of childbirth (hazard ratio [HR] with 95% confidence interval was 0.78 (0.68-0.90)). Subgroup analysis showed that the rate was not significantly reduced in essential thrombocythemia, HR 1.02 (0.86-1.22) while the HR was 0.50 (0.33-0.76) in PV and 0.45 (0.28-0.74) in PMF. The risk of miscarriage was not significantly increased before MPN diagnosis, the HR during follow-up after diagnosis was 1.25 (0.89-1.76). Women with MPN were more likely to have had a previous stillbirth. Women with MPN had fewer children at diagnosis, and fewer children in total. In conclusion, the childbirth rate was lower among women with MPN than controls, but not among women with essential thrombocythemia.
骨髓增殖性肿瘤(MPN)与妊娠结局不良相关,但关于 MPN 女性的生育能力和生育潜力知之甚少。在这项研究中,我们旨在描述生殖模式,并量化流产和死产的风险。1973 年至 2018 年间,在瑞典医疗保健登记处确定了年龄在 15-44 岁之间患有 MPN 诊断的女性,并按年龄与人群对照组 1:4 匹配。我们确定了 1141 名患有 MPN 的女性和 4564 名对照者。患有 MPN 的女性生育率较低(95%置信区间的风险比为 0.78(0.68-0.90))。亚组分析表明,原发性血小板增多症的比率没有明显降低,HR 为 1.02(0.86-1.22),而 PV 的 HR 为 0.50(0.33-0.76),PMF 的 HR 为 0.45(0.28-0.74)。在 MPN 诊断之前,流产风险并未显著增加,诊断后随访期间的 HR 为 1.25(0.89-1.76)。患有 MPN 的女性更容易有先前的死产。患有 MPN 的女性在诊断时的孩子较少,并且总孩子数较少。总之,患有 MPN 的女性的生育率低于对照组,但原发性血小板增多症女性的生育率没有差异。